$ABXX the dashboard URL has moved to abxxtracker.com - please update any bookmarks accordingly

An open letter to Shelly shareholders. I believe €70 undervalues the business. Several fellow shareholders and I intend not to tender on the announced terms. The board owes us a clear valuation case. $SLYG @PhantasTrader @simon_haeger @SharogradskyM @Aktieing @BG_kmeta

Bro, just use the passkey. It’s in the magic link. It’s in your authenticator app. We sent you a code. It’s 2FA with your phone and yubikey. It’s face id. It’s sign in with SSO. Just enable touch id. Do you want to stay signed in? (we’ll log you out anyways)

$slyg Just listened to call, as a shareholder you should pray this stays public. They can’t comment on the buyout discussions. I don’t care if the offer is 80 or 90, smart move is just stay public and let management continue to run the show. If even 5 percent of my companies ran their business like these guys I would be in very good shape.

$ABXX.TO bulls, @nobenchmark has added delivery month tags e.g. (Dec) to his excellent abxxtracker.com/. I use this website every day so thanks again @nobenchmark

Situational Awareness is the best name for a fund blowup since Long Term Capital Management

An early buyout was always my fear with $slyg. I hope they turn it down unless the premium is massive.

Playfulness is the highest intelligence. Watch a genius work, he's joylaughing. Watch a fool work, he's furious. Seriousness is a mask worn by men who fear being seen playing. God made dolphins, puppies, and orgasms. The evidence is in. He wants us laughing.

$SLYG -Reports prelim revs for H1 of €68.3M (+27% y/y) inline with expectations -Cash increased by 62% q/q on improved OCF and AR -Cash level is already close to lower end of year-end guidance of €35-45M

$qure $clpt Since @MartinShkreli is talking to the koka on July 5th, looks like they might only be discussing other topics but Martin if you get a chance ask the Koka what is his explanation for the nfl readings, the MRI images and Tfc readings on amt 130. I haven’t heard a good answer on any of those topics. Since Koka “the Huntington’s expert” keeps posting that this drug doesn’t work I think he should have a good explanation for those. Ask him after 4 1/2 years on 6 patients how are they remaining stable? That is 6 at 4 1/2 years and 1 at 5 years. Since he treats Huntington’s patients according to the Koka, we would like to know how Tabrizi has never seen anyone go back to work in 30 years, Wild in 20 years and Sung has never seen this type of response. We hope the Koka has some solid answers as the true HD expert.

Fuck

Totally normal

AC psychosis

How the fuck is this “just in”

What cracks me up about this $abxx.to story is everyone I’ve spoken to on Bay Street and/or in the commodities space is bullish Abaxx and then you look up this dude who’s bearish, turns out he’s a failed social worker. Really tough to decide whose expertise to trust here

.@viceroyresearch indirectly admits to being paid to write the $abxx.to short report. When asked if he was paid to write the report, @AIMhonesty replies “I was not paid to short Abaxx.” Refuses to put in writing that they weren’t paid to write the report, knowing it’d be a lie.

We don’t have wash trades. (not even sure how it would be possible to clear our own wash trades, through market surveillance, ISV logic, and third party cleaning, even if we wanted to) Full stop. Come on, y’all, let’s use our heads.

This you?